Asian Journal of Research in Pharmaceutical Sciences

Sangeet Kumar Mall ¹, Priti Dipa ¹, Shambaditya Goswami ², Prashant Singh ³, Ravindra Pal Singh ⁴

Affiliations
1 NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan., IN
2 Divine College of Pharmacy, Siwan, Bihar., IN
3 Buddha Institute of Pharmacy, GIDA, Gorakhpur, U.P.,, IN
4 NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, IN

Abstract

According to WHO, Pharmacovigilance (PV) is characterized as the science and exercises identifying with the recognition, appraisal, comprehension and anticipation of unfavourable impacts or some other medication related issue. It is an important part of our medication guideline framework. As we know, India is the world's second most populated country with very nearly one billion dynamic and potential medication buyers and clients. Though our country is participating in Uppsala Monitoring Centre, its obligation to that data base is by and pretty much nothing. This issue is due to the lack of proper ADR (Adverse drug reaction) monitoring system and awareness among associates of medicines and health workers. PV program mainly aims for patient care, patient safety and monitoring of adverse drug reaction. For the accurate practice of PV in India, there are need of more clinical preliminaries and clinical examinations. For the safe and sensible use of medication, a perfectly working PV system is mandatory. PV will be invaluable in India not only for medical services experts, regulatory authorities, pharmaceutical organizations but also for the consumers to screen the medicines. This article gives a methodical audit of the pharmacovigilance program in India (PvPI) from its starting point to the current situation and furthermore examines the future parts of pharmacovigilance program in India.

Keywords

Pharmacovigilance, Adverse drug reactions, Patient care, Patient safety, PvPI.

Full Text